SCREEN GRAB VIA YOUTUBE

Texas Board Rejects Clemency Plea for Chris Young and Solidifies Tonight's Death Sentence

UPDATE: July 18, 2018 at 8:13 a.m. ET:

Mitesh Patel, the victim’s son and Chris Young’s advocate did not want the same outcome for Young’s daughter—losing a father. But the state of Texas executed Young on Tuesday anyway. He was pronounced dead at 6:38 p.m. after a lethal injection.

Patel did meet Young on Monday in an emotional meeting and felt sadness for his family.

“Two wrongs don’t make a right,” Patel has said. “Killing Chris doesn’t change my path, my history. It only affects a whole other set of people.”

Young used his last moments to tell his victim’s family he loves them and to keep fighting.

Young’s final statement: “l want to make sure the Patel family knows I love them like they love me. Make sure the kids in the world know I’m being executed and those kids I’ve been mentoring keep this fight going. I’m good, Warden.”

ORIGINAL STORY

The Texas Board of Pardons unanimously rejected clemency for Chris Young, the reformed death row inmate, and lawyers say it is because Young is Black. The law says the board doesn’t have to give the public a reason for their decision, but they have to certify it’s not because of race.


Not too long ago the board unanimously granted clemency and a life sentence in place of execution to a white inmate, Thomas Whitaker, who was convicted in the planned deaths of his family in 2003 to get inheritance money. His father, who survived his injuries, was his biggest advocate.

Young’s lawyer, David Dow, said in the recent filing, “Both Whitaker and Young were transformed. Both expressed genuine remorse. Both were forces of positive good in prison. And perhaps most significantly of all, the closest surviving relatives of the murders opposed the execution.”

“This vote is most likely explained by a single variable — a variable the Constitution precludes decision-makers from taking into account: race,” Dow wrote, citing the criminal justice system’s history of racial disparities.

The legal team additionally has asked for Texas Gov. Greg Abbott to allow a stay of execution so Young and Mitesh Patel, the victim’s son and Young’s advocate, can meet. “Doing so will demonstrate the same spirit of mercy that Mr. Patel has so courageously shown.”

Attorney General Stephen Hoffman said against the claims of racism that that Young’s case was weaker than Whitaker’s, and that lawyers left out previous misdemeanor convictions, an alleged sexual assault before Patel’s murder, the fact that Young was the killer where Whitaker was a conspirator and disciplinary reports from death row.

Lawyers pointed out no disciplinary records were on file past 2012.

Texas has only stopped an execution three times since 1998, while 400 others went on as planned.

Related Story: Son of Murder Victim Pleads for the Black Man’s Life as Texas Decides Today Whether or Not to Execute Next Week

Latest News

What Friends Tell Friends: Choose Kaiser Permanente

Originally published on about.kaiserpermanente.org. Integrated, nonprofit health plan tops NICE Satmetrix customer experience benchmark study for 10th straight year. For the 10th year in a row, more people would recommend Kaiser Permanente to a friend or colleague than any other health plan in the nation, according to the recently released…

Cesar Conde

NBCUniversal Sets Ambitious 50% Diversity Goal for Women, People of Color

Cesar Conde, chairman at NBCUniversal News Group, announced a groundbreaking goal to have a 50% diverse workforce at NBCUniversal, according to Deadline. Conde, the first Latino in this role, outlined his plans in an internal video for employees on Wednesday. The ultimate goal is for NBCUniversal, No. 7 on DiversityInc’s 2020…

Mastercard Expands ShopOpenings.com to the U.S. & Canada, Delivering a Search Tool That Identifies What Stores Near You Are Open for Business

Originally published on mastercardcontentexchange.com. Search solution complements new Digital Acceleration for Small Business global initiative which helps small businesses advance digitally and drive online commerce As businesses seek to draw customers back both in store and online, Mastercard is introducing new tools to support them. Today, Mastercard announced the geographic…

TIAA Launches Programs to Raise Awareness of Racial Injustice and Support Communities in Need through the “Be The Change” Initiative

On June 30, TIAA announced new virtual programs designed to raise awareness of racial injustice and support communities in need as a part of the company’s recently launched “Be the Change” initiative. One is TIAA’s “Race Against Racism,” an effort in support of The Innocence Project which included more than…

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

Originally published on jnj.com. Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic In 2020, the initiative aims to reach at least 125,000 patients and could…

Toyota, Alabama A&M and Huntsville Hospital Collaborate to Make COVID-19 Testing Easier

Originally published on pressroom.toyota.com. $100,000 grant provides free service to the community Alabama A & M University (AAMU), Huntsville Hospital and Toyota are developing a mobile health clinic initiative to provide free COVID-19 testing to underserved communities in Madison County. Launching later this year, the mobile medical clinic program has…

Sanofi and Regeneron Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

Originally published on sanofi.com. Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo)….